ABSTRACT
Purpose: To characterize a genetic mutation causing Stickler syndrome in a previously undiagnosed family.
Methods: Five generations of a single family suspected of having Stickler syndrome were evaluated clinically and genetically.
Results: The demographic and clinical data yielded specific clinical phenotypes of Stickler syndrome in 13 family members; 7 had more than one clinical feature. Four family members underwent genetic analysis: the proband (index patient) and his mother, maternal grandfather, and healthy father. No relevant mutation was detected in the proband on whole exome analysis, but subsequent extension of the analysis to intronic areas yielded a deep intronic mutation, NM_001844.5:c.1527 + 135 G > A. Sanger sequencing was used to validate the results in the family members.
Conclusions: Stickler syndrome has several subtypes with variable clinical features. Therefore, predicting the genetic locus of the disease based on clinical characteristics is challenging. We present a rarely described intronic mutation in COL2A1. Genetic testing may aid in the early diagnosis of Stickler syndrome, which is important for genetic counselling, proper clinical management, and improved prognosis.
Author contributions
SRW designed the experiment, conducted the experiment, analysed/interpreted the data, wrote the article, proofread/revised article. NO interviewed the family members, conducted the experiment, analysed/interpreted the data, proofread/revised article. AZ analysed/interpreted the data, wrote the article, proofread/revised article. NG-C designed the experiment, conducted the experiment, analysed/interpreted the data, wrote the article, proofread/revised article. NG-C had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Declaration of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.
Ethics statement
The study was approved by the institutional review board, and all patients or guardians gave written informed consent for participation.